2025-05-12T18:24:49-05:00 2024-06-30 262246506 APERCEN PARTNERS LLC 314 LYTTON AVE PALO ALTO CA 94301 990 2023-07-01 872786093 CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY INST 6508047100 11755 WILSHIRE BOULEVARD 1400 LOS ANGELES CA 90025 ERIC ESRAILIAN PRESIDENT 6508047100 2025-05-12 1 1 TOM M VAN LOBEN SELS P00447955 6508047100 2023 2025-03-06 01:10:19Z ERIC ESRAILIAN 11755 WILSHIRE BOULEVARD 1400 LOS ANGELES CA 90025 1000000 0 X HTTPS://WWW.CALIMMUNOLOGY.ORG X 2021 CA MEDICAL SCIENCES RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE IMMUNE SYSTEM 6 6 0 10 0 0 1108746 1000000 0 0 0 0 0 0 1108746 1000000 0 0 0 0 0 0 0 0 0 933834 462208 933834 462208 174912 537792 192284 1008545 17372 295841 174912 712704 TO HARNESS THE POWER OF THE HUMAN IMMUNE SYSTEM AND ADVANCED COMPUTING TECHNOLOGIES TO CREATE AND TRANSLATE SCIENTIFIC DISCOVERIES INTO NEXT GENERATION VACCINES AND THERAPIES FOR PREVENTION, CONTROL AND CURE OF CHRONIC DISEASES, ENABLING LONGER AND HEALTHIER LIVES. 0 0 340563 THE INSTITUTE IS A MEDICAL SCIENCES RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE IMMUNE SYSTEM AND ITS VARIED ROLES IN THE PATHOGENESIS AND POTENTIAL TREATMENT OF A WIDE VARIETY OF DISEASES, WITH A MISSION TO DEEPLY DECODE THE WORKINGS OF THE HUMAN IMMUNE SYSTEM TO PROMOTE HEALTH, COMBAT DISEASE AND PROLONG LIFE. THE INSTITUTE WAS ESTABLISHED TO CREATE A MULTIDISCIPLINARY MEDICAL RESEARCH INSTITUTE TO COORDINATE RESEARCH INTO THE HUMAN IMMUNE SYSTEM ACROSS UNIVERSITIES AND RESEARCH INSTITUTIONS IN CALIFORNIA. THE INSTITUTE ALSO PLANS TO ENGAGE IN THE CONTINUOUS AND ACTIVE CONDUCT OF MEDICAL RESEARCH IN COLLABORATION WITH VARIOUS NONPROFIT HOSPITALS. 340563 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 4 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 0 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 CA X APERCEN PARTNERS LLC 6508047100 314 LYTTON AVE PALO ALTO CA 94301 X GARY MICHELSON BOARD CHAIR/DIRECTOR 5.00 1.00 X X 0 0 0 ERIC ESRAILIAN PRESIDENT/DIRECTOR 1.00 1.00 X X 0 0 0 MEYER LUSKIN TREASURER/SECRETARY/DIRECTOR 1.00 1.00 X X 0 0 0 ARIE BELLDEGRUN DIRECTOR 1.00 1.00 X 0 0 0 MICHAEL MILKEN DIRECTOR 1.00 1.00 X 0 0 0 SEAN PARKER DIRECTOR 1.00 1.00 X 0 0 0 0 0 0 0 0 0 0 ARNOLD & PORTER KAYE SCHOLER LLP 601 MASSACHUSETTS AVE NW WASHINGTON DC 20001 LEGAL 116631 1 1000000 1000000 1000000 0 0 0 425704 340563 85141 36304 36304 200 200 462208 340563 121645 0 192284 1008545 192284 1008545 17372 295841 17372 295841 X 0 0 0 0 174912 712704 174912 712704 192284 1008545 537792 0 X 0 0 0 X 1108746 1000000 2108746 1108746 1000000 2108746 957825 1150921 2108746 X SCHEDULE A, PART II - EXPLANATION FOR SHORT YEAR THE 2020 TAX YEAR, WHICH IS THE ORGANIZATION'S FISCAL YEAR ENDING JUNE 30, 2021, WAS A SHORT YEAR, COVERING THE PERIOD APRIL 8, 2021, THROUGH JUNE 30, 2021, DUE TO IT BEING THE ORGANIZATION'S FIRST YEAR IN EXISTENCE. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION A, LINE 7A THE CORPORATION'S DESIGNATOR, CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY FOUNDERS LLC, HAS THE POWER TO REMOVE DIRECTORS AND FILL VACANCIES ON THE BOARD. FORM 990, PART VI, SECTION A, LINE 7B ANY AMENDMENTS TO THE CORPORATION'S ARTICLES OF INCORPORATION AND BYLAWS ARE SUBJECT TO THE WRITTEN CONSENT OF THE CORPORATION'S DESIGNATOR, CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY FOUNDERS LLC. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE AND LEGAL COUNSEL AND THEN DISTRIBUTED TO THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE INSTITUTE HAS A CONFLICT OF INTEREST POLICY THAT REQUIRES DIRECTORS, OFFICERS, KEY EMPLOYEES AND OTHER DESIGNATED INDIVIDUALS TO DISCLOSE IF THEY HAVE A PERSONAL INTEREST OR RELATIONSHIP IN A TRANSACTION INVOLVING THE INSTITUTE, WHETHER DIRECTLY OR INDIRECTLY THROUGH A FAMILY MEMBER, CONTROLLED ENTITY OR BUSINESS OR INVESTMENT RELATIONSHIP. ANY INDIVIDUAL WITH A PERSONAL INTEREST OR RELATIONSHIP IN A TRANSACTION INVOLVING THE INSTITUTE MUST BE RECUSED FROM THE DISCUSSIONS AND APPROVAL FOR THAT TRANSACTION. THE TRANSACTION MUST BE REVIEWED BY DISINTERESTED PERSONS WHO DO NOT HAVE A PERSONAL INTEREST IN THE TRANSACTION UNDER REVIEW, AND SUCH DISINTERESTED PERSONS MAY APPROVE THE TRANSACTION AFTER DETERMINING THAT THE TERMS ARE FAIR AND REASONABLE TO THE INSTITUTE. THE INSTITUTE MAY ALSO CONSIDER WHETHER THERE ARE ALTERNATIVE TRANSACTIONS OR ARRANGEMENTS THAT ARE REASONABLY AVAILABLE UNDER THE CIRCUMSTANCES THAT DO NOT PRESENT A POTENTIAL CONFLICT OF INTEREST. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST WHEN REQUIRED BY FEDERAL OR STATE LAW. CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY FOUNDERS LLC 314 LYTTON AVE PALO ALTO CA 94301 882383224 PROFESSIONAL SERVICES CA N/A NONE 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0